Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07124546
NA

Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers

Sponsor: Mayo Clinic

View on ClinicalTrials.gov

Summary

This clinical trial studies whether Acceptance and Commitment Therapy for patients with hepatobiliary cancers (ACT-HBC) can be used to help improve cancer distress. Patients with hepatobiliary cancer (HBC) often experience high levels of distress and reductions in quality of life. ACT-HBC is a behavioral intervention tailored to patients with HBC. It helps patients cope with difficult thoughts and emotions while staying connected to what matters most in life, which may be an effective way to improve cancer distress.

Official title: Development of Acceptance and Commitment Therapy for Cancer Distress Among Rural and Urban Patients With Hepatobiliary Cancers (ACT-HBC)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2025-05-28

Completion Date

2027-05-30

Last Updated

2025-08-15

Healthy Volunteers

No

Interventions

BEHAVIORAL

Acceptance and Commitment Therapy

Attend ACT-HBC telehealth group sessions

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Telemedicine

Attend ACT-HBC telehealth group sessions

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States